|
1
|
Marrelli A, Cipriani P, Liakouli V, et al:
Angiogenesis in rheumatoid arthritis: a disease specific process or
a common response to chronic inflammation? Autoimmun Rev.
10:595–598. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lajas C, Abasolo L, Bellajdel B, et al:
Costs and predictors of costs in rheumatoid arthritis: a
prevalence-based study. Arthritis Rheum. 49:64–70. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smolen JS, Aletaha D, Koeller M, Weisman
MH and Emery P: New therapies for treatment of rheumatoid
arthritis. Lancet. 370:1861–1874. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Aletaha D, Neogi T, Silman AJ, et al: 2010
Rheumatoid arthritis classification criteria: an American College
of Rheumatology/European League Against Rheumatism collaborative
initiative. Arthritis Rheum. 62:2569–2581. 2010. View Article : Google Scholar
|
|
5
|
Bartok B and Firestein GS: Fibroblast-like
synoviocytes: key effector cells in rheumatoid arthritis. Immunol
Rev. 233:233–255. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tobon GJ, Youinou P and Saraux A: The
environment, geo-epidemiology, and autoimmune disease: Rheumatoid
arthritis. Autoimmun Rev. 9:A288–A292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Smolen JS, Aletaha D, Bijlsma JW, et al:
Treating rheumatoid arthritis to target: recommendations of an
international task force. Ann Rheum Dis. 69:631–637. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guma M, Hammaker D, Topolewski K, et al:
Antiinflammatory functions of p38 in mouse models of rheumatoid
arthritis: advantages of targeting upstream kinases MKK-3 or MKK-6.
Arthritis Rheum. 64:2887–2895. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Le Goff B, Blanchard F, Berthelot JM,
Heymann D and Maugars Y: Role for interleukin-6 in structural joint
damage and systemic bone loss in rheumatoid arthritis. Joint Bone
Spine. 77:201–205. 2010.PubMed/NCBI
|
|
10
|
Damjanov N, Kauffman RS and Spencer-Green
GT: Efficacy, pharmacodynamics, and safety of VX-702, a novel p38
MAPK inhibitor, in rheumatoid arthritis: results of two randomized,
double-blind, placebo-controlled clinical studies. Arthritis Rheum.
60:1232–1241. 2009. View Article : Google Scholar
|
|
11
|
Buch MH and Emery P: New therapies in the
management of rheumatoid arthritis. Curr Opin Rheumatol.
23:245–251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Isomaki HA, Hakulinen T and Joutsenlahti
U: Excess risk of lymphomas, leukemia and myeloma in patients with
rheumatoid arthritis. J Chronic Dis. 31:691–696. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Smitten AL, Simon TA, Hochberg MC and
Suissa S: A meta-analysis of the incidence of malignancy in adult
patients with rheumatoid arthritis. Arthritis Res Ther. 10:R452008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Olson AL, Swigris JJ, Sprunger DB, et al:
Rheumatoid arthritis-interstitial lung disease-associated
mortality. Am J Respir Crit Care Med. 183:372–378. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cloonan N, Forrest AR, Kolle G, et al:
Stem cell transcriptome profiling via massive-scale mRNA
sequencing. Nat Methods. 5:613–619. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mortazavi A, Williams BA, McCue K,
Schaeffer L and Wold B: Mapping and quantifying mammalian
transcriptomes by RNA-Seq. Nat Methods. 5:621–628. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Gerstein M and Snyder M: RNA-Seq:
a revolutionary tool for transcriptomics. Nat Rev Genet. 10:57–63.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ozsolak F and Milos PM: RNA sequencing:
advances, challenges and opportunities. Nat Rev Genet. 12:87–98.
2011. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Heruth DP, Gibson M, Grigoryev DN, Zhang
LQ and Ye SQ: RNA-seq analysis of synovial fibroblasts brings new
insights into rheumatoid arthritis. Cell Biosci. 2:432012.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang LQ, Cheranova D, Gibson M, et al:
RNA-seq reveals novel transcriptome of genes and their isoforms in
human pulmonary microvascular endothelial cells treated with
thrombin. PLoS One. 7:e312292012. View Article : Google Scholar
|
|
21
|
Cheranova D, Gibson M, Chaudhary S, et al:
RNA-seq analysis of transcriptomes in thrombin-treated and control
human pulmonary microvascular endothelial cells. J Vis Exp.
e43932013. View
Article : Google Scholar
|
|
22
|
Cox MP, Peterson DA and Biggs PJ:
SolexaQA: At-a-glance quality assessment of Illumina
second-generation sequencing data. BMC Bioinformatics. 11:4852010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Trapnell C, Pachter L and Salzberg SL:
TopHat: discovering splice junctions with RNA-Seq. Bioinformatics.
25:1105–1111. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Trapnell C, Williams BA, Pertea G, et al:
Transcript assembly and quantification by RNA-Seq reveals
unannotated transcripts and isoform switching during cell
differentiation. Nat Biotechnol. 28:511–515. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Trapnell C, Roberts A, Goff L, et al:
Differential gene and transcript expression analysis of RNA-seq
experiments with TopHat and Cufflinks. Nat Protoc. 7:562–578. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
R Core Team. R: A language and environment
for statistical computing. R Foundation for Statistical Computing;
Vienna, Austria: 2013
|
|
27
|
Beissbarth T and Speed TP: GOstat: find
statistically overrepresented Gene Ontologies within a group of
genes. Bioinformatics. 20:1464–1465. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moriya Y, Itoh M, Okuda S, Yoshizawa A and
Kanehisa M: KAAS: an automatic genome annotation and pathway
reconstruction server. Nucleic Acids Res. 35:W182–W185. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xie C, Mao X, Huang J, et al: KOBAS 2.0: a
web server for annotation and identification of enriched pathways
and diseases. Nucleic Acids Res. 39:W316–W322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Brooker DS: Rheumatoid arthritis:
otorhinolaryngological manifestations. Clin Otolaryngol Allied Sci.
13:239–246. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gierut A, Perlman H and Pope RM: Innate
immunity and rheumatoid arthritis. Rheum Dis Clin North Am.
36:271–296. 2010. View Article : Google Scholar
|
|
32
|
Scott DL, Wolfe F and Huizinga TW:
Rheumatoid arthritis. Lancet. 376:1094–1108. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Felson DT, Smolen JS, Wells G, et al:
American College of Rheumatology/European League against Rheumatism
provisional definition of remission in rheumatoid arthritis for
clinical trials. Ann Rheum Dis. 70:404–413. 2011. View Article : Google Scholar
|
|
34
|
Maeda K, Kobayashi Y, Udagawa N, et al:
Wnt5a-Ror2 signaling between osteoblast-lineage cells and
osteoclast precursors enhances osteoclastogenesis. Nat Med.
18:405–412. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sonomoto K, Yamaoka K, Oshita K, et al:
Interleukin-1β induces differentiation of human mesenchymal stem
cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like
orphan receptor 2 pathway. Arthritis Rheum. 64:3355–3363. 2012.
|
|
36
|
Srivastava SK, Antal P, Gal J, et al: Lack
of evidence for association of two functional SNPs of CHI3L1 gene
(HC-gp39) with rheumatoid arthritis. Rheumatol Int. 31:1003–1007.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kazakova M, Batalov A, Deneva T, Mateva N,
Kolarov Z and Sarafian V: Relationship between sonographic
parameters and YKL-40 levels in rheumatoid arthritis. Rheumatol
Int. 33:341–346. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen CC, Llado V, Eurich K, Tran HT and
Mizoguchi E: Carbohydrate-binding motif in chitinase 3-like 1
(CHI3L1/YKL-40) specifically activates Akt signaling pathway in
colonic epithelial cells. Clin Immunol. 140:268–275. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Johansen JS, Stoltenberg M, Hansen M, et
al: Serum YKL-40 concentrations in patients with rheumatoid
arthritis: relation to disease activity. Rheumatology (Oxford).
38:618–626. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Malemud CJ: Matrix metalloproteinases
(MMPs) in health and disease: an overview. Front Biosci.
11:1696–1701. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tchetverikov I, Ronday HK, Van El B, et
al: MMP profile in paired serum and synovial fluid samples of
patients with rheumatoid arthritis. Ann Rheum Dis. 63:881–883.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jungel A, Ospelt C, Lesch M, et al: Effect
of the oral application of a highly selective MMP-13 inhibitor in
three different animal models of rheumatoid arthritis. Ann Rheum
Dis. 69:898–902. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Corvaisier M, Delneste Y, Jeanvoine H, et
al: IL-26 is overexpressed in rheumatoid arthritis and induces
proinflammatory cytokine production and Th17 cell generation. PLoS
Biol. 10:e10013952012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sedwick C: IL-26 kick-starts rheumatoid
arthritis. PLoS Biol. 10:e10013982012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gemelli C, Montanari M, Tenedini E, et al:
Virally mediated MafB transduction induces the monocyte commitment
of human CD34+ hematopoietic stem/progenitor cells. Cell Death
Differ. 13:1686–1696. 2006.PubMed/NCBI
|
|
46
|
Bakri Y, Sarrazin S, Mayer UP, et al:
Balance of MafB and PU.1 specifies alternative macrophage or
dendritic cell fate. Blood. 105:2707–2716. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Sato T, Konomi K, Yamasaki S, et al:
Comparative analysis of gene expression profiles in intact and
damaged regions of human osteoarthritic cartilage. Arthritis Rheum.
54:808–817. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Trenkmann M, Brock M, Gay RE, et al:
Expression and function of EZH2 in synovial fibroblasts: epigenetic
repression of the Wnt inhibitor SFRP1 in rheumatoid arthritis. Ann
Rheum Dis. 70:1482–1488. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
de Rooy DP, Yeremenko NG, Wilson AG, et
al: Genetic studies on components of the Wnt signalling pathway and
the severity of joint destruction in rheumatoid arthritis. Ann
Rheum Dis. 72:769–775. 2013.PubMed/NCBI
|
|
50
|
Sen M, Reifert J, Lauterbach K, et al:
Regulation of fibronectin and metalloproteinase expression by Wnt
signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum.
46:2867–2877. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sen M: Wnt signalling in rheumatoid
arthritis. Rheumatology (Oxford). 44:708–713. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lu C, Xiao C, Chen G, et al: Cold and heat
pattern of rheumatoid arthritis in traditional Chinese medicine:
distinct molecular signatures indentified by microarray expression
profiles in CD4-positive T cell. Rheumatol Int. 32:61–68. 2012.
View Article : Google Scholar
|
|
53
|
Maciejewska-Rodrigues H, Karouzakis E,
Strietholt S, et al: Epigenetics and rheumatoid arthritis: the role
of SENP1 in the regulation of MMP-1 expression. J Autoimmun.
35:15–22. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Kim KS, Choi HM, Lee YA, et al: Expression
levels and association of gelatinases MMP-2 and MMP-9 and
collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of
patients with arthritis. Rheumatol Int. 31:543–547. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Nakki A, Kouhia ST, Saarela J, et al:
Allelic variants of IL1R1 gene associate with severe hand
osteoarthritis. BMC Med Genet. 11:502010. View Article : Google Scholar : PubMed/NCBI
|
